Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli
Open Access
- 1 May 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 1 (4) , e1500077
Abstract
Type I modular polyketide synthases are responsible for potent therapeutic compounds that include avermectin (antihelinthic), rapamycin (immunosuppressant), pikromycin (antibiotic), and erythromycin (antibiotic). However, compound access and biosynthetic manipulation are often complicated by properties of native production organisms, prompting an approach (termed heterologous biosynthesis) illustrated in this study through the reconstitution of the erythromycin pathway through Escherichia coli. Using this heterologous system, 16 tailoring pathways were introduced, systematically producing eight chiral pairs of deoxysugar substrates. Successful analog formation for each new pathway emphasizes the remarkable flexibility of downstream enzymes to accommodate molecular variation. Furthermore, analogs resulting from three of the pathways demonstrated bioactivity against an erythromycin-resistant Bacillus subtilis strain. The approach and results support a platform for continued molecular diversification of the tailoring components of this and other complex natural product pathways in a manner that mirrors the modular nature of the upstream megasynthases responsible for aglycone polyketide formation.Keywords
This publication has 58 references indexed in Scilit:
- Recent advances in the heterologous expression of microbial natural product biosynthetic pathwaysNatural Product Reports, 2013
- Investigating Mithramycin Deoxysugar Biosynthesis: Enzymatic Total Synthesis of TDP‐D‐OlivoseChemBioChem, 2011
- Development of a Streptomyces venezuelae-Based Combinatorial Biosynthetic System for the Production of Glycosylated Derivatives of Doxorubicin and Its Biosynthetic IntermediatesApplied and Environmental Microbiology, 2011
- Engineered Biosynthesis of Gilvocarcin Analogues with Altered Deoxyhexopyranose MoietiesApplied and Environmental Microbiology, 2011
- Improved precursor-directed biosynthesis in E. coli via directed evolutionThe Journal of Antibiotics, 2010
- Generation of New Derivatives of the Antitumor Antibiotic Mithramycin by Altering the Glycosylation Pattern through Combinatorial BiosynthesisChemBioChem, 2008
- Engineered Biosynthesis of Macrolide Derivatives Bearing the Non-Natural Deoxysugars 4-epi-d-Mycaminose and 3-N-Monomethylamino-3-Deoxy-d-FucoseJournal of the American Chemical Society, 2007
- Bioassay-Guided Evolution of Glycosylated Macrolide Antibiotics in Escherichia coliPLOS Biology, 2007
- Combinatorial Biosynthesis of Antitumor Deoxysugar Pathways in Streptomyces griseus : Reconstitution of “Unnatural Natural Gene Clusters” for the Biosynthesis of Four 2,6- d -DideoxyhexosesApplied and Environmental Microbiology, 2006
- Combinatorial biosynthesis of reduced polyketidesNature Reviews Microbiology, 2005